-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Influenza-A-virus-IN-8
Category | Influenza Virus |
Description | Influenza A virus-IN-8 (S5) is a macrocyclic peptide with no cytotoxic. Influenza A virus-IN-8 is also a potent Influenza A Virus (IAV) inhibitor (with sufficient protease stability) with IC50s of 6.7 and 6.6 nM for H1 and H5 variants, respectively. Influenza A virus-IN-8 shows good affinitiescan to H1 variants, binds to a conserved region in the HA stem with a Kd of 1.0 nM. |
Product Information
Synonyms | Influenza A virus-IN-8|CS-0566212 |
Molecular Weight | 2200.48 |
Molecular Formula | C104H142N28O24S |
Canonical SMILES | CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1)CC(C)C)C(C)O)CC2=CN=CN2)CC(=O)O)CC3=CNC4=CC=CC=C43)CCCNC(=N)N)CC5=CC=CC=C5)CC(C)C)C(C)C)CC6=CC=C(C=C6)O)C(=O)NCC(=O)N)C(C)C)CC7=CNC8=CC=CC=C87)CC9=CN=CN9)C(C)O |
Purity | ≥98% (HPLC) |
Solubility | In vitro: 10 mM in DMSO |
Appearance | Solid powder |
Storage | Store at -20°C |
Complexity | 4840 |
Exact Mass | 2200.0506035 |
In Vitro | Influenza A virus-IN-8 (5 μM; 72 h) does not affect viability of HeLa and MDCKI cells. Influenza A virus-IN-8 (5 μM; 24 h) shows neutralizing effect on H1N1pdm09 and H5N1 in a dose-dependent manner. Influenza A virus-IN-8 (5 nM; 2 h) binds to a conserved region in the HA stem with Kd of 1.0 nM for H1 variants. Influenza A virus-IN-8 (5 μM; 1 h) inhibits HA fusion activity during entry by stabilizing the prefusion conformation. |
In Vivo | Influenza A virus-IN-8 (5 μM; 72 h) does not affect viability of HeLa and MDCKI cells. |
Target | Influenza Virus |
XLogP3-AA | 2.4 |